Document Detail


A case of paraneoplastic nephrotic syndrome in a patient with ovarian carcinoma.
MedLine Citation:
PMID:  12833596     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Nephrotic syndrome is a rare manifestation of malignancy associated with paraneoplastic syndrome. Paraneoplastic nephrotic syndrome has been reported in various malignancies: malignant lymphoma, colon cancer, lung cancer and prostate cancer. However, an ovarian carcinoma associated with nephrotic syndrome has rarely been reported. Only six cases of ovarian carcinoma associated paraneoplastic nephrotic syndrome has been reported worldwide, but no cases have been reported in Korea. Here, we report a case of paraneoplastic nephrotic syndrome in a patient with an ovarian carcinoma. The patient presented with ascites, proteinuria and hypoalbuminemia. An initial computed tomography (CT) scan and ultrasonography evaluations showed no specific findings suggestive of an ovarian tumor. Despite treatment for nephrotic syndrome, the symptoms became more aggravated. There after, follow up evaluation at Yonsei University Medical Center, including serum CA 125, pelvis MRI and peritoneal fluid examination were performed. On the pelvis MRI, a left ovarian mass was detected with an ascitic fluid collection. The serum CA 125 level was elevated to 2211 U/ml. The peritoneal fluid cytological examination showed malignant cells suggestive of an ovarian carcinoma. Combination chemotherapies including paclitaxel plus carboplatin, topotecan plus gemcitabine and oxaliplatin plus capecitabine were administered to the patient, and complete remission was achieved on image and tumor marker studies. There was complete recovery from the nephrotic syndrome with no evidence of ascites and proteinuria. These findings suggest that nephrotic syndrome caused by paraneoplastic syndrome can be resolved only after the complete control of the underlying malignancy.
Authors:
Yong Tai Kim; Sun Young Rha; Chi Young Shim; Joo Hyuk Sohn; Chul Kim; Nae Choon Yu; Hyun Cheol Chung; Joo Hang Kim; Dae Suk Han; Byung Soo Kim; Jae Kyung Roh
Related Documents :
10411356 - Hemolytic uremic syndrome associated with immunoglobulin a nephropathy: a case report a...
11065256 - Type ii diabetes mellitus and primary sjögren's syndrome complicated by pleural effusion.
17316196 - Encephalopathy after furosemide use in nephrotic syndrome.
3511756 - Cholestatic jaundice after hepatic transplantation. a nonimmunologically mediated event.
11810626 - Thumb radial angulation correction without phalangeal osteotomy in apert's syndrome.
20616506 - Diagnosis of cure in cushing's syndrome: lessons from long-term follow-up.
Publication Detail:
Type:  Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Yonsei medical journal     Volume:  44     ISSN:  0513-5796     ISO Abbreviation:  Yonsei Med. J.     Publication Date:  2003 Jun 
Date Detail:
Created Date:  2003-06-30     Completed Date:  2003-09-05     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0414003     Medline TA:  Yonsei Med J     Country:  Korea (South)    
Other Details:
Languages:  eng     Pagination:  539-43     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine, Yonsei University College of Medicine, 134 Shinchon-dong, Seodaemun-gu, Seoul 120-752, Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Carcinoma / complications*,  diagnosis,  drug therapy
Female
Humans
Magnetic Resonance Imaging
Middle Aged
Nephrotic Syndrome / complications*,  drug therapy
Ovarian Neoplasms / complications*,  diagnosis,  drug therapy
Paraneoplastic Syndromes / complications*,  drug therapy
Remission Induction
Tomography, Emission-Computed
Tomography, X-Ray Computed

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Autoimmune pancreatitis with effective steroid therapy.
Next Document:  Endobronchial metastasis of hepatocellular carcinoma.